A study at the University of Edinburgh shows an increased risk of heart attack with a job involving high temperature such as a firefighting. In a study, 19 healthy and non-smoking people from the Scottish Fire and Rescue Service were subjected to an extremely high temperature. Researchers monitored the participants with the heart monitor. The researchers observed the following health issues in the participants after exposing them to an extremely high temperature.
Researchers think that the loss of fluid in the body and the body response to inflammation has caused the thickening of the blood and a higher risk of blood clot. Researchers say the risk of heart attack with an extremely high temperature will be reduced if the people in a job involving a high temperature are well hydrated.
This study was funded by the British Heart Foundation (BHF). Lead author of the study was Prof Nick Mills, a research fellow at the University of Edinburgh and the study was published in the Circulation.
Researchers at the University Of California have developed a new drug in the form of a pill to reverse type 2 diabetes (T2D) by the inhibition of the low molecular weight protein tyrosine phosphatase (LMPTP) enzyme.
The new drug can restore the insulin sensitivity of the cells of the patient with diabetes. A study of the newly developed drug on the obese mice models with a high blood sugar (glucose) levels was successful in reversing the type 2 diabetes (T2D).
The researchers say that LMPTP activity can lower insulin sensitivity of the cell. The weakened insulin response can increase the blood sugar levels in the body (a risk of type 2 diabetes). The newly developed drug can reduce the activity of an enzyme called LMPTP and restore the functionality of the cell and the insulin sensitivity.
The trial with mice models shows no adverse side effects. The researchers say more study on the new drug is required to prove the safety of the drug for the human trial.
Researchers are very optimistic that the new drug can be a new therapeutic strategy for the reversal of type 2 diabetes. The lead author of the study was Stephanie M Stanford and the study was published in the journal Nature.
A study on 264,337 people over a period of five years at the University of Glasgow shows a lower risk of cardiovascular disease, premature death from any cause (mortality) and cancer if the person swaps the bus or car pass with a cycle. The daily walking can benefit the health of a person. But the benefits of walking are less than the benefits of cycling.
The study was published in the British Medical Journal (BMJ).
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.